Related Experiment Video
Updated: Feb 27, 2026

12:54
Determination of Vaccine Immunogenicity Using Bovine Monocyte-Derived Dendritic Cells
Published on: May 19, 2023
2.4K
Bovine Viral Diarrhea Virus and Vaccine Protection Strategies
Xinyao Hu1, Jing Huang1, Yafei Cai1
1College of Animal Science and Technology, Nanjing Agricultural University, Nanjing 210095, China.
Veterinary Sciences
|February 26, 2026
Summary
Bovine viral diarrhea virus (BVDV) causes significant cattle industry losses. New vaccine technologies and integrated control strategies are crucial for managing BVDV and preventing persistent infections.
Area of Science:
- Veterinary Virology
- Immunology
- Epidemiology
Background:
- Bovine viral diarrhea virus (BVDV) poses a major threat to global cattle health and economies.
- Persistent infection, immunosuppression, and reproductive issues are key BVDV-induced problems.
- Viral genetic diversity and immune evasion mechanisms complicate BVDV control.
Purpose of the Study:
- To review the challenges in BVDV control and prevention.
- To evaluate limitations of current BVDV vaccines.
- To explore novel vaccine platforms and integrated control strategies for BVDV.
Main Methods:
- Literature review of BVDV pathogenesis, epidemiology, and control strategies.
- Analysis of limitations associated with inactivated (IVs) and modified live (MLVs) BVDV vaccines.
- Assessment of emerging vaccine platforms (mRNA, subunit, multi-epitope) and AI-driven design.
Main Results:
- BVDV persistently infects cattle, creating reservoirs for transmission and causing economic losses.
- Conventional vaccines have limitations including subtype mismatch and safety concerns.
- Novel platforms like mRNA and multi-epitope vaccines show promise for improved BVDV immunity.
Conclusions:
- Effective BVDV control requires addressing limitations of current vaccines and exploring new technologies.
- AI-driven design and molecular surveillance can enhance vaccine development.
- Integrated strategies including PI animal clearance, vaccination, and biosecurity are vital for sustainable BVDV management.
Related Concept Videos
Vaccinations
52.3K
Overview
52.3K
Cancer Vaccines
1.2K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.2K

